In September 2016 the Council began an inquiry into ethical issues raised by genome editing as an emerging biomedical technology that could influence inherited characteristics in human beings.

The potential development of genome editing applications in human reproduction was one of the areas identified as requiring urgent ethical scrutiny in our 2016 report Genome editing: an ethical review.

Genome editing techniques such as the CRISPR-Cas9 system are transforming many areas of biological research.

Most uses of genome editing have so far been in scientific research – for example to investigate models of human disease. However, given that genome editing has the potential to alter any DNA sequence, whether in a bacterium, plant, animal or human being, it has an almost limitless range of possible applications in living things. If you want to find out more about genome editing, read our brief guide.

We are undertaking an ongoing programme of work on genome editing, split into three strands:

1. Genome editing: an ethical review – published in 2016
2. Genome editing and human reproduction: social and ethical issues – published in July 2018
3. Genome editing and livestock – to begin in 2018

Recent global health emergencies have highlighted how uncertainties about what is ethically acceptable during emergencies can impede progress of potentially valuable research, or alternatively contribute to the risks of unethical practice passing undetected.

This project will explore how research may be conducted ethically in global health emergencies.

Bioethics briefing notes are a different type of output from the Nuffield Council on Bioethics. Each briefing note will focus on new scientific and medical developments and the ethical and social issues raised around a particular topic.